glp 1 and psoriatic arthritis Glucagon-like peptide its receptor agonists for the treatment of rheumatic diseases GLP-1 Drugs for Psoriatic Arthritis:

In 1972 Habener became an investigator at the same hospital and Harvard Medical School

J Allergy Clin Immunol 136(5):12771287

Take-home message: Enlicitide significantly reduced atherogenic lipoproteins and was well tolerated offering a promising oral PCSK9-targeting strategy for high-risk HeFH patients inadequately controlled on current therapy

PMID: 2555512 PMC1572913 Pigmentation Pathway (MC1R, Preclinical) Eumelanin upregulation via cAMP / MITF / tyrosinase axis MC1R activation by melanocortin agonists is reported to raise intracellular cAMP, upregulate MITF, and increase tyrosinase-mediated eumelanin synthesis in epidermal melanocyte models